Scinovex
article Open AccessTop 1% cited

Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis

European Respiratory Journal · 2020 · Vol. 55(5) · pp. 2000547–2000547
Wei-Jie GuanWenhua LiangYi ZhaoHeng-rui LiangZi‐Sheng ChenYimin LiXiaoqing LiuRu-chong ChenChun-li TangTao WangChun‐Quan OuLi LiPing-Yan ChenLing SangWei WangJian-fu LiCaichen LiLi-min OuBo ChengShan XiongZheng-yi NiJie XiangYu HuLei LiuHong ShanChun-liang LeiYi-xiang PengLi WeiYong LiuYa-hua HuPeng PengJian Ming WangJiyang LiuZhong ChenGang LiZhi-jian ZhengShao-qin QiuJie LuoChang-jiang YeShao-yong ZhuLin-ling ChengFeng YeShi-yue LiJin-ping ZhengNuo-fu ZhangNanshan ZhongJian-xing He

Abstract

Among laboratory confirmed cases of COVID-19, patients with any comorbidity yielded poorer clinical outcomes than those without. A greater number of comorbidities also correlated with poorer clinical outcomes.

COVID-19 Clinical Research StudiesChronic Disease Management StrategiesCOVID-19 epidemiological studiesMedicineComorbidityInternal medicineDiabetes mellitusIntensive care unitCoronavirus disease 2019 (COVID-19)PopulationCOPDHazard ratioDisease

MeSH terms

BetacoronavirusCOVID-19SARS-CoV-2AdultChinaFemaleHumansMaleMiddle AgedPneumonia, ViralPrognosisRisk FactorsComorbidityCoronavirus InfectionsPandemics

Funding

  • Guangzhou Medical University
  • Guangdong Science and Technology Department
  • Southern Medical University
  • National Health Commission of the People's Republic of China
Citations
3,762
FWCI
89.14
field-weighted impact
References
36
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.